The Role of Eicosapentaenoic Acid for Residual Cardiovascular Risk Despite Statin Therapy

Author

Donald Vertrees, University of the PacificFollow

Date of Award

4-1-2020

Document Type

Capstone

Degree Name

Master of Physician Assistant Studies

Department

Physician Assistant Education

First Advisor

Rahnea Sunseri

Abstract

Cardiovascular disease (CVD) was responsible for over 840,000 deaths in the United States in 2016 and costs an estimated $352 billion annually in both direct and indirect costs. Approximately every 40 seconds, an American will have an acute myocardial infarction (AMI), and at a similar rate an American will have a stroke. In patients who experienced AMI from 2010 to 2016, statin use at hospital discharge increased from 92% to 99%. Nonetheless, cardiovascular disease remains the leading cause of death in the United States and more than one million coronary events are expected to occur in individuals in 2019; approximately 335,000 of those cases will be recurrent coronary events. 1 Understanding the risk factors for CVD and then reducing those risks have the potential to decrease the impact of this disease.

Recommended Citation

Vertrees, Donald, "The Role of Eicosapentaenoic Acid for Residual Cardiovascular Risk Despite Statin Therapy" (2020). Physician Assistant Capstones. 83.
https://scholarlycommons.pacific.edu/pa-capstones/83